UPDATE AVAILABLE ON-DEMAND
“The global smart syringes market is driven by the rise in count of needle stick injuries, shift from conventional syringes to smart syringes, growth in awareness in the emerging economies, and widespread adoption of safety syringes across all applications, especially in drug delivery. In addition, rise in mandatory regulations laid by WHO about the use of smart syringes is further expected to boost the market growth. However, high cost associated with smart syringes and alternative drug delivery methods are expected to hamper the market growth.”
The report offers in-depth analyses of the market size; key market segments; drivers, restraints, challenges, opportunities; and marketing strategies adopted by leading market companies across the globe. According to the report, the global smart syringe market garnered $5.74 billion in 2017 and is expected to $13.79 billion by 2025, registering CAGR of 10.3% through 2025.
High prevalence of blood-borne transmissions such as Hepatitis B, C, and HIV through improper injection practices, rise in incidence of needlestick injuries, and increased adoption of safety syringes in healthcare settings drive the growth of the market. However, high cost associated with smart syringes and low awareness in developing countries hamper the market growth. On the contrary, mandatory recommendation by the WHO to promote the use of smart syringes is expected to create lucrative opportunities for the market players in the coming years.
Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/838
Global Smart Syringe Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.
Passive safety syringes segment to manifest fastest growth by 2025
The passive safety syringe segment is expected to grow at the fastest CAGR of 14.7% through 2025, owing to the high demand for passive safety syringes with integrated retractable needles, which have safety features and an automatic working mechanism. However, the active safety syringes segment accounted for about two-thirds share of the market in 2017. Moreover, the auto-disable syringes segment would portray gradual growth during the study period.
Vaccination segment to become fastest growing segment by 2025
The vaccination segment is expected to register the fastest CAGR of 16.8% owing to the high demand for immunization services provided through vaccination. However, the drug delivery segment held the largest market share in 2017, contributing about 96% of the total market revenue. This is attributed to the associated advantages such as better bioavailability of intravenous drugs, shorter onset time, and accurate titration of the dosage. In addition, blood specimen collection segment would witness significant growth from 2018 to 2025.
Adult age group segment to be the major revenue contributor through 2025
In 2017, the adult segment held the highest market share, contributing about 83% of the total market, and is expected to continue its dominance throughout the study period. However, the pediatrics segment is expected to register the fastest CAGR of 13% through 2025, owing to increase in the number patients suffering from transmitted infections, especially in the age group of 0-18 years.
Major end users in the market
The key end users of the global smart syringe market include hospital, diabetic patients, family practices, psychiatric, and others. In 2017, the hospital segment held about one-third share of the market revenue and is projected to maintain this trend during the forecast period. However, the psychiatric segment would grow at the fastest CAGR of 14.9% during the forecast period, owing to increase in affordability in the developing region and stringent regulations by government bodies regarding the use of safety syringes.
North America to dominate the global market through 2025
North America region contributed the highest market share in 2017, accounting for 42% of the total market revenue, owing to high buying power, stringent regulations, and well-developed healthcare infrastructure. However, the Asia-Pacific region would manifest the fastest CAGR of 13.6% during the study period due to rise in awareness about these products by regulatory bodies such as WHO, UNICEF, and others. The other regions analyzed in the study are Europeand Latin America, Middle East and Africa (LAMEA).
For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/838
The Major Key Players Are:
Dickinson and Company, Terumo Medical Corporation, Baxter International, Unilife Corporation, Retractable Technologies, Inc., Becton, Cardinal Health, B. Braun Melsungen AG, Smiths Group plc, and Gerresheimer AG.
The report analyzes the growth strategies adopted by these market players, which include product launches, partnerships, collaborations, mergers & acquisition, joint ventures, and others to strengthen their position in the industry.
Scope of the Report:
|Market size available for years||2017-2025|
|Base year considered||2017|
|Forecast units||Value (USD)|
|Segments covered||Product Type, Application, Age Group and End User|
|Geographies covered||North America, Europe, Asia-Pacific, LAMEA|
Pneumonia Vaccine Market by Vaccine Type (Pneumococcal Conjugate Vaccine, and Pneumococcal Polysaccharide Vaccine), by Product Type (Prevnar 13, Synflorix, and Pneumovax 23) and By Sector (Public and Private), by Distribution Channel (Distribution Partner Companies, Non-governmental Organizations and Government Authorities): Opportunity Analysis and Industry Forecast, 2018–2025
Cholera Vaccine Market by Product (Dukoral, Shanchol, Vaxchora, Euvichol & Euvichol-Plus, and others) and End User (Hospitals & Clinics, Research & Academic Laboratories, and Others): Global Opportunity Analysis and Industry Forecast, 2018 – 2025
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Follow Us on Twitter: https://twitter.com/marketresearcht